プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
fasteplasmaglucose (fpg) (mmol/l)
fasting plasma glucose (fpg) (mmol/l)
最終更新: 2017-04-26
使用頻度: 1
品質:
fasteplasmaglucose skal monitoreres før initiering af behandling med ceritinib og periodisk derefter som klinisk indiceret.
monitoring of fasting serum glucose is required prior to the start of ceritinib treatment and periodically thereafter as clinically indicated.
最終更新: 2017-04-26
使用頻度: 1
品質:
patienter skal monitoreres for fasteplasmaglucose før behandling med zykadia påbegyndes og periodisk derefter som klinisk indiceret.
patients should be monitored for fasting plasma glucose prior to the start of zykadia treatment and periodically thereafter as clinically indicated.
最終更新: 2017-04-26
使用頻度: 1
品質:
de stigninger, der ses i fasteplasmaglucose og hba1c ved pasireotid til intramuskulær anvendelse, er reversible efter seponering.
the elevations of fasting plasma glucose and hba1c observed with pasireotide intramuscular use treatment are reversible after discontinuation.
最終更新: 2017-04-26
使用頻度: 1
品質:
behandling med 25 mg alogliptin én gang dagligt medførte statistisk signifikante forbedringer i hba1c og fasteplasmaglucose fra baseline til uge 26 sammenholdt med placebogruppen (tabel 3).
treatment with 25 mg alogliptin once daily resulted in statistically significant improvements from baseline in hba1c and fasting plasma glucose compared to placebo-control at week 26 (table 3).
最終更新: 2017-04-26
使用頻度: 1
品質:
dette blev fastlagt på grundlag af klinisk relevante og statistisk signifikante fald i glykosyleret hæmoglobin (hba1c) og i fasteplasmaglucose sammenlignet med kontrol fra baseline og til endepunkt.
this was determined by clinically relevant and statistically significant reductions in glycosylated haemoglobin (hba1c) and fasting plasma glucose compared to control from baseline to study endpoint.
最終更新: 2017-04-26
使用頻度: 1
品質:
endvidere var den gennemsnitlige ændring i fasteplasmaglucose fra baseline til uge 52 for 25 mg alogliptin og metformin signifikant større end for glipizid og metformin (p < 0,001).
mean change from baseline in fasting plasma glucose at week 52 for 25 mg alogliptin and metformin was significantly greater than that for glipizide and metformin (p<0.001).
最終更新: 2017-04-26
使用頻度: 1
品質:
警告:見えない HTML フォーマットが含まれています
ved uge 104 var den gennemsnitlige ændring i fasteplasmaglucose fra baseline for 25 mg alogliptin og metformin - 3,2 mg/dl sammenlignet med 5,4 mg/dl for glipizid og metformin.
by week 104, mean change from baseline in fasting plasma glucose for 25 mg alogliptin and metformin was -3.2 mg/dl compared with 5.4 mg/dl for glipizide and metformin.
最終更新: 2017-04-26
使用頻度: 2
品質:
med novomix 30 opnåede henholdsvis 66% og 42% af patienterne hba1c niveauer på under 7% og 6, 5%, og middel fasteplasmaglucose (fpg) blev reduceret med ca.7 mmol/l (fra 14, 0 mmol/l ved baseline til 7, 1 mmol/l) .
with novomix 30, 66% and 42% of the patients reached hba1c levels below 7% and 6.5%, respectively, and mean fpg was reduced by about 7 mmol/l (from 14.0 mmol/l at baseline to 7.1 mmol/l) .
最終更新: 2008-03-04
使用頻度: 2
品質:
警告: このアラインメントは正しくない可能性があります。
間違っていると思う場合は削除してください。